Boc-γ-Aminobutyric acid

Online Inquiry

CAT#CP02804
CAS57294-38-9
Synonyms/Alias57292-45-2;Boc-D-Phe(4-F)-OH;BOC-D-4-Fluorophe;Boc-4-fluoro-D-phenylalanine;BOC-d-4-Fluorophenylalanine;N-(tert-Butoxycarbonyl)-4-fluoro-D-phenylalanine;boc-4-fluoro-d-phe;(R)-2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoicacid;boc-p-fluoro-d-phe-oh;boc-4-fluoro-d-phe-oh;(2r)-2-[(tert-butoxycarbonyl)amino]-3-(4-fluorophenyl)propanoicacid;boc-p-fluoro-d-phenylalanine;N-Boc-4-fluoro-D-phenylalanine;(r)-n-boc-4-fluorophenylalanine;4-fluoro-d-phenylalanine,n-bocprotected;(r)-2-tert-butoxycarbonylamino-3-(4-fluoro-phenyl)-propionicacid;ST50826091;n-alpha-t-butyloxycarbonyl-d-4-fluorophenylalanine;(r)-2-(tert-butoxycarbonylamino)-3-(4-fluorophenyl)propanoicacid;PubChem6123;AC1Q1MTN;AC1MC19F;BOC-D-PHE(4-F);KSC911S3P;15351_ALDRICH
M.F/FormulaC14H18FNO4
M.W/Mr.203.24
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Mambalgin 1, a toxin isolated from black mamba venom, is a disulfide-rich polypeptide consisting of 57 amino aci ...

In the respiratory tract, there are tachykinin P (SP) and neurokinin A (NKA) in capsaicin-sensitive primary affe ...

 GR 94800, is a linear heptapeptide with the structure of PhCO-Ala-Ala-D-Trp-Phe-D-Pro-Nle Amide, which is a high ...

  Perindopril erbumine is an angiotensioncon vertingenzyme (ACE) inhibitor without sulfhydryl group. It is a chi ...

 Astressin 2B is a peptidic antagonist to CRF2 (corticotrophin-releasing factor 2) receptor with structure of cyc ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.